-
-
-
-
-
-
-
Eagle Pharmaceuticals Announces Acceptance of Two Abstracts at the Society for Academic Emergency Medicine (SAEM) Annual Meeting
-
-
-
-
-
-
-
Eagle Pharmaceuticals (EGRX) Provides Business Update, Guidance for 2023
-
-
-
-
-
-
-
Eagle Pharmaceuticals and Enalare Therapeutics Announce Additional Award Worth Up to $50 Million from BARDA to Advance an Intramuscular (“IM”) Formulation of ENA-001
-
-
-
-
-
-
-
Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker
-
-
-
-
-
-
-
Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth
-
-
-
-
-
-
-
Notable Mergers and Acquisitions 11/11: (VNTV) (EGRX) (DSGX)
-
-
-
-
-
-
-
Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600
-
1,154,869 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

